Featured Research

from universities, journals, and other organizations

Progress In Battle Against Life-threatening Acute Allergy

Date:
August 3, 2006
Source:
VIB, Flanders Interuniversity Institute of Biotechnology
Summary:
Up to 15 percent of the population has to contend at some time with anaphylaxis: a suddenly serious allergic reaction that can be life-threatening. Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to Ghent University have uncovered mechanisms that underlie this reaction. Their research offers new perspectives for the treatment of anaphylactic shock.

Up to 15% of the population has to contend at some time with Anaphylaxis: a suddenly serious allergic reaction that can be life-threatening. Researchers from the Flanders Interuniversity Institute for Biotechnology (VIB) connected to Ghent University have uncovered mechanisms that underlie this reaction. Their research offers new perspectives for the treatment of anaphylactic shock.

Anaphylaxis
Some people have allergic reactions to certain substances that can be so pronounced that they affect the entire body. Such a reaction − called anaphylaxis − can be so severe that it becomes life-threatening. An injection of adrenalin is currently the only effective remedy known for this condition. But adrenalin often has no, or insufficient, effect on the cardiovascular collapse that is a consequence of the allergic shock.

Anaphylaxis occurs fairly frequently and strikes up to 15% of the population. It can be caused by a bee sting, by medications, by contact with latex, or by certain foods such as peanuts. Because more and more people are being confronted with anaphylactic shock, and given the limitations of the current treatment methods, scientists are searching for better remedies.

Several leading actors
Scientists are aware of the possible role of PAF (Platelet Activating Factor) in blood pressure and heart disorders that result from shock like anaphylactic shock. They also know that extreme amounts of nitric oxide (NO) can lie at the basis of shock. The so-called NOS enzymes are responsible for the production of NO in the body. However, the role of NO in producing anaphylactic shock, or how shock is induced by PAF, has always been unclear. So, Anje Cauwels and her colleagues, under the leadership of Peter Brouckaert, have been focusing their attention on anaphylaxis to try to shed more light on these matters.

The mechanism exposed
The Ghent researchers used mice to study PAF and anaphylactic shock. To their great surprise, the hyper-acute PAF-induced shock was completely dependent on NO. Furthermore, the production of NO was not regulated by iNOS (the expected activator) but by the constitutive eNOS, which is activated via the PI3K pathway. Up to now, scientists have thought that this pathway only plays a role in normal blood pressure regulation, and not in shock.

The research team then set out to verify whether inhibition of the several leading actors could prevent anaphylactic shock. And indeed, from their research it turns out that inhibition of eNOS or PI3K provides total protection.

New perspectives for future therapies
The research of Cauwels and Brouckaert has yielded an unexpected new finding: namely, that eNOS-derived NO plays a key role in anaphylactic shock. This discovery opens new perspectives for treatment − it's now clear that eNOS and PI3K are prime targets for new drugs against anaphylaxis.


Story Source:

The above story is based on materials provided by VIB, Flanders Interuniversity Institute of Biotechnology. Note: Materials may be edited for content and length.


Cite This Page:

VIB, Flanders Interuniversity Institute of Biotechnology. "Progress In Battle Against Life-threatening Acute Allergy." ScienceDaily. ScienceDaily, 3 August 2006. <www.sciencedaily.com/releases/2006/08/060803083137.htm>.
VIB, Flanders Interuniversity Institute of Biotechnology. (2006, August 3). Progress In Battle Against Life-threatening Acute Allergy. ScienceDaily. Retrieved August 31, 2014 from www.sciencedaily.com/releases/2006/08/060803083137.htm
VIB, Flanders Interuniversity Institute of Biotechnology. "Progress In Battle Against Life-threatening Acute Allergy." ScienceDaily. www.sciencedaily.com/releases/2006/08/060803083137.htm (accessed August 31, 2014).

Share This




More Health & Medicine News

Sunday, August 31, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
3 Things To Know About The Ebola Outbreak's Progression

3 Things To Know About The Ebola Outbreak's Progression

Newsy (Aug. 29, 2014) Here are three things you need to know about the deadly Ebola outbreak's progression this week. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins